↓ Skip to main content

Through the looking glass: understanding non-inferiority

Overview of attention for article published in Trials, May 2011
Altmetric Badge

Mentioned by

blogs
4 blogs
policy
3 policy sources
twitter
134 X users
facebook
2 Facebook pages
reddit
1 Redditor
q&a
1 Q&A thread

Citations

dimensions_citation
335 Dimensions

Readers on

mendeley
666 Mendeley
citeulike
5 CiteULike
Title
Through the looking glass: understanding non-inferiority
Published in
Trials, May 2011
DOI 10.1186/1745-6215-12-106
Pubmed ID
Authors

Jennifer Schumi, Janet T Wittes

Abstract

Non-inferiority trials test whether a new product is not unacceptably worse than a product already in use. This paper introduces concepts related to non-inferiority, and discusses the regulatory views of both the European Medicines Agency and the United States Food and Drug Administration.

X Demographics

X Demographics

The data shown below were collected from the profiles of 134 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 666 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 14 2%
Canada 3 <1%
Australia 2 <1%
Brazil 2 <1%
Sweden 2 <1%
Ireland 1 <1%
Norway 1 <1%
United Kingdom 1 <1%
Germany 1 <1%
Other 5 <1%
Unknown 634 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 137 21%
Student > Ph. D. Student 103 15%
Other 84 13%
Student > Master 57 9%
Professor > Associate Professor 37 6%
Other 139 21%
Unknown 109 16%
Readers by discipline Count As %
Medicine and Dentistry 271 41%
Agricultural and Biological Sciences 41 6%
Psychology 36 5%
Mathematics 24 4%
Pharmacology, Toxicology and Pharmaceutical Science 22 3%
Other 124 19%
Unknown 148 22%